TRXBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
TRex Bio, Inc.
$14.80+0.79 (+5.64%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Debt
Borrowings on the balance sheet
TRex Bio reports no long-term debt line
Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.
Bond issues
Individual notes and bonds outstanding
Bond-level data is not connected yet
Coupon, maturity and amount of each note will come from the debt footnote in TRex Bio's annual report. Trading prices and yields need FINRA TRACE data.